WXXWY Stock — Price, Charts & Analysis

WuXi Biologics (Cayman) Inc. (WXXWY) has a trailing P/E of 36.91x. This places WXXWY in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

WXXWY trades with 36.91x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether WXXWY looks overvalued or undervalued.

WXXWY's P/E of 36.91x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

WXXWY's trailing EPS is $0.34. Reported earnings growth is 39.40%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit WuXi Biologics (Cayman) Inc. generated for each share. WXXWY's trailing EPS is $0.34, and investors usually prefer EPS that is positive and growing over time.

WuXi Biologics (Cayman) Inc. has a market cap of $25.77B, making WXXWY a large-cap stock based on the current market value shown on Worldtickers.

WXXWY's latest stock price on Worldtickers is $12.55. The latest move is $0.22 or 1.78%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

WXXWY's quote includes a latest price of $12.55. The market open is $12.49. Previous close is $12.33. The intraday range is $12.49 to $12.60.

WXXWY is up in the latest quote, with a move of $0.22 or 1.78%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

WXXWY generated $21.79B in trailing revenue. Revenue growth is 17.20%, which helps show whether demand is expanding or slowing.

WXXWY's revenue growth is 17.20%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, WXXWY shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is $4.91B.

Gross margin is 45.98%. Margins show how efficiently WuXi Biologics (Cayman) Inc. turns revenue into profit.

WuXi Biologics (Cayman) Inc. carries $3.10B and holds $15.73B in cash.

WXXWY holds $15.73B on its balance sheet.

WXXWY's book value per share is $3.39.

Institutions hold 0.01% of WXXWY shares. Insiders hold 0.00% of shares. Ownership mix helps investors understand how much of WuXi Biologics (Cayman) Inc. is held by professional investors and company insiders.

WXXWY has 2.05B shares outstanding. Float shares are 1.87B. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for WXXWY, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Earnings growth is 39.40%. Revenue growth is 17.20%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

WXXWY's trailing EPS is $0.34. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

WXXWY is in the Healthcare sector. Its earnings multiple is 36.91x. Its latest displayed growth metric is 17.20%. Compare these figures with sector peers before deciding whether WuXi Biologics (Cayman) Inc. is stronger or weaker than average.

WXXWY trades at $12.55. The stock trades at 36.91x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of WuXi Biologics (Cayman) Inc.'s fundamentals.

WXXWY risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.60, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

WXXWY should be compared with companies in Biotechnology. Its earnings multiple is 36.91x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

WuXi Biologics (Cayman) Inc. (WXXWY) operates in Healthcare, specifically Biotechnology. WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contra

WXXWY trades on OTC Markets OTCPK. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

WXXWY stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

WuXi Biologics (Cayman) Inc.'s official website listed on Worldtickers is www.wuxibiologics.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

WuXi Biologics (Cayman) Inc. employs about 13.25K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

WuXi Biologics (Cayman) Inc. is headquartered in Wuxi, China. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

WXXWY is in the Healthcare sector and the Biotechnology industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

WXXWY has traded between $7.30 and $12.60 over the past 52 weeks. At $12.55, it is 0.40% below the high and 71.92% above the low. The 52-week range helps gauge long-term price momentum.

WXXWY is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is $9.62 and its 200-day moving average is $9.10.

WXXWY's RSI is 78.46. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a overbought momentum setup.

WXXWY's latest RSI reading is 78.46, which points to overbought momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for WXXWY is near $9.57. Key resistance is near $12.46. Breaks above resistance or below support can change the short-term technical setup.

WXXWY's nearest reported support level is $9.57. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

WXXWY's nearest reported resistance level is $12.46. A breakout above resistance can improve momentum, especially when volume confirms the move.

WXXWY trades about 88.7K shares daily on average. The latest displayed volume is 18.53K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

WXXWY's MACD is 0.14, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

WXXWY is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 78.46 (overbought). MACD is bullish. Nearest support is around $9.57. Resistance is around $12.46. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $10.86 (15.56% from price). MA50 is $9.62 (30.49% from price). MA200 is $9.10 (37.91% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. WXXWY's MA20 is $10.86. MA50 is $9.62. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

WXXWY's pivot is near $12.32. Support is near $9.57. Resistance is near $12.46. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for WXXWY is near $10.13. These levels help define risk and possible follow-through zones after a breakout or breakdown.

WXXWY's Bollinger range is roughly $8.84 to $12.88. Band width is near 37.23%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

WXXWY's ATR-based typical daily range is about 3.41%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 18.53K shares. Average volume is about 88.7K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

WXXWY's all-time high shown on Worldtickers is $38.00. Its all-time low is $1.17. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

WXXWY has a beta of 0.60, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.